Synthesis and biological evaluation of novel 4-oxo-5-cyano thiouracil derivatives as SecA inhibitors
Heterocyclic Communications · 17.05.2020 · 26 (1) · 76-83
DOI: 10.1515/hc-2020-0100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Heterocyclic Communications, online erschienen am 17.05.2020. Verfasst von Fante Bamba und 3 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The continuous emergence of drug-resistant strains of bacteria poses an urgent risk to human health and dictates the need for new antimicrobials. Along this line, we have been working on developing inhibitors of SecA, a key component of the bacterial Sec-dependent secretion machinery. Herein, we describe the synthesis and antimicrobial evaluation of 6-oxo-1,6-dihydropyrimidine-5-carbonitrile derivatives as potential SecA inhibitors.
Zitieren
APA
Bamba, F., Jin, J., Tai, P. C., & Wang, B. (2020). Synthesis and biological evaluation of novel 4-oxo-5-cyano thiouracil derivatives as SecA inhibitors. Heterocyclic Communications, 26(1), 76-83. https://doi.org/10.1515/hc-2020-0100
Vancouver
Bamba F, Jin J, Tai PC, Wang B. Synthesis and biological evaluation of novel 4-oxo-5-cyano thiouracil derivatives as SecA inhibitors. Heterocyclic Communications. 2020;26(1):76-83. doi:10.1515/hc-2020-0100
BibTeX
@article{Bamba2020,
author = {Bamba, Fante and Jin, Jinshan and Tai, Phang C. and Wang, Binghe},
title = {Synthesis and biological evaluation of novel 4-oxo-5-cyano thiouracil derivatives as SecA inhibitors},
journal = {Heterocyclic Communications},
year = {2020},
volume = {26},
number = {1},
pages = {76--83},
doi = {10.1515/hc-2020-0100}
}
EUVIMED